Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sciele buys remainder of partner Addrenex for $29mm in cash

Executive Summary

Shionogi's US division Sciele Pharma has acquired Addrenex Pharmaceuticals, a privately held company developing adrenergic dysregulation therapeutics. Sciele, a significant shareholder, will pay $29mm in cash for the Addrenex shares it does not already own.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Payment Includes Cash

Related Companies